Wenlong Zhong

9PUBLICATIONS
37CO-AUTHORS
Cellular nervous systemMolecular targetsTumour immunologyPredictive and prognostic markersInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 27, 2026
Single-cell profiling of natural killer/T-cell lymphoma reveals stratified immune features and potential therapeutic implications.

|Jan 17, 2024
Tumor-associated neutrophils suppress CD8+ T cell immunity in urothelial bladder carcinoma through the COX-2/PGE2/IDO1 Axis.

Yi Ouyang, Wenlong Zhong, Peiqi Xu

|Oct 17, 2023
Effective Antitumor Immunity Can Be Triggered by Targeting VISTA in Combination with a TLR3-Specific Adjuvant.

Bo Wang, Ziwei Ou, Wenlong Zhong

|Sep 28, 2023
FGFR3 Alterations in Bladder Cancer Stimulate Serine Synthesis to Induce Immune-Inert Macrophages That Suppress T-cell Recruitment and Activation.

Yi Ouyang, Ziwei Ou, Wenlong Zhong

|Nov 17, 2022
The tumour-associated stroma correlates with poor clinical outcomes and immunoevasive contexture in patients with upper tract urothelial carcinoma: results from a multicenter real-world study (TSU-01 Study).

Longhao Xu, Wenlong Zhong, Chenchen Li

|Dec 28, 2021
Identification of an IDO1-based immune classifier for survival prediction of upper tract urothelial carcinoma.

Wenlong Zhong, Meng Yang, Sida Cheng

Pageof 2

Frequent Collaborators

4 joint publications

Tianxin Lin

4 joint publications

Jian Huang

2 joint publications

Junyu Chen

2 joint publications

Ziwei Ou